Findings from HERTHENA-Lung02 showed that the key secondary endpoint of overall survival did not meet statistical significance.

Ken Burns, one of the most critically acclaimed documentary filmmakers of the modern age, says the current threats to defund public media are likely the most existential the system has ever seen ...

Adding the immune checkpoint inhibitor durvalumab (Imfinzi) to the standard chemotherapy regimen of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) improved event-free survival (EFS) in ...

A Cathedral City man is among the growing list of Democrats who have announced plans to run against Inland Rep. Ken Calvert in 2026. Jason Byors, 54, hopes to unseat Calvert, R-Corona, in California’s ...

Ken Takeshita, global head, R&D, Daiichi Sankyo, said: “Enhertu continues to transform the treatment of metastatic breast cancer with the first new data in more than a decade to demonstrate improved ...

In a bold move toward a more sustainable future, Daiichi Properties has partnered with Shell Energy Philippines to power its office buildings with renewable energy. The agreement, which took ...

DESTINY-Breast09 shows that initiating treatment with Enhertu in combination with pertuzumab at the time of metastatic diagnosis can delay disease progression,” said Ken Takeshita, Global Head, R&D, ...

Ken Takeshita, Global Head, R&D, Daiichi Sankyo, said: “ENHERTU continues to transform the treatment of metastatic breast cancer with the first new data in more than a decade to demonstrate improved ...

Susan Galbraith of AstraZeneca and Ken Takeshita of Daiichi Sankyo echoed the sentiment, highlighting the potential for ENHERTU to transform the treatment landscape and delay disease progression.